View an illustration about the life cycle of the malaria parasite.
Malaria is rampant in sub-Saharan Africa, and effective control of the disease is being threatened by growing drug resistance in the malaria parasite and insecticide resistance in malaria-transmitting mosquitoes.
In The Gambia, researchers supported by NIAID are testing an alternate strategy for malaria control: the use of larvicides that kill larvae of Anopheles gambiae, the mosquito responsible for spreading the disease.
To test their hypothesis, the researchers are assessing the effectiveness and impact on transmission of two microbial larvicides: Bacillus thuringiensis var.israelensis (Bti) and B. sphaericus (Bs). Both larvicides are desirable because they specifically target mosquito larvae and do not appear to elicit resistance.
Researchers established four study sites along the River Gambia covering roughly 100 square kilometers each. During the rainy season (July to November), the river rises and floods wide areas, resulting in intense transmission of malaria and an increase in clinical cases of the disease.
So far, the researchers have been able to identify the sources of malaria mosquitoes in each of the four study areas and establish the most effective strategy for killing larvae using Bti and Bs, including the best combination of the two larvicides and the most efficient length of time before re-treatments. They have also developed a method for large-scale application in the study areas.
The latest results from this study show that the use of microbial larvicides in The Gambia significantly reduced the abundance of anopheline mosquitoes in natural habitats. More results are expected from this study after data from the 2007 field trial are analyzed.
See the associated article in Malaria Journal .
back to top
Last Updated March 26, 2008